Feasibility and Cost Analysis of Ambulatory Endovascular Aneurysm Repair.

abdominal aortic aneurysm cost analysis endovascular aneurysm repair hospital costs same-day discharge

Journal

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists
ISSN: 1545-1550
Titre abrégé: J Endovasc Ther
Pays: United States
ID NLM: 100896915

Informations de publication

Date de publication:
08 Nov 2022
Historique:
entrez: 8 11 2022
pubmed: 9 11 2022
medline: 9 11 2022
Statut: aheadofprint

Résumé

We sought to compare the costs of ambulatory endovascular aneurysm repair (a-EVAR) and inpatient EVAR (i-EVAR) at up to 1-year of follow-up. A retrospective cohort study of consecutive patients undergoing elective EVAR between April 2016 and December 2018 at two academic centers. Patients planned for a-EVAR were compared with i-EVAR. Costs at 30 days and 1 year were extracted. These included operating room (OR) use, bed occupancy, laboratory and imaging, emergency department (ED) visits, readmissions, and reinterventions. Baseline characteristics were compared. Multiple regression model was used to identify predictors of increased EVAR costs. Repeated measures analysis of variance (ANOVA) was used to compare cost differences at 30 days and 1 year via an intention-to-treat analysis. Bonferroni post hoc test compared between-group differences. A p value<0.05 was considered statistically significant. One hundred seventy patients were included. Most underwent percutaneous EVAR (>94%) under spinal anesthesia (>84%). Ambulatory endovascular aneurysm repair was successful in 84% (84/100). Ambulatory endovascular aneurysm repair patients (76±8 years) were younger than i-EVAR (78±9 years). They also had a smaller mean aneurysm diameter (56±6 mm) compared with i-EVAR (59±6 mm). Emergency department visits, readmissions, and reinterventions were similar up to 1 year (all p=NS). Ambulatory endovascular aneurysm repair costs showed a non-statistically significant reduction in total costs at 30 days and 1 year by 27% and 21%, respectively. Patients younger than 85 years and males had a 30-day cost reduction by 34% (p=0.027) and 33% (p=0.035), respectively with a-EVAR. Same-day discharge is feasible and successful in selected patients. Patients younger than 85 years and males have a short-term cost benefit with EVAR done in the ambulatory setting without increased complications or reinterventions. This study shows the overall safety of ambulatory EVAR with proper patient selection. These patient had similar post-intervention complications to inpatients. Same day discharge also resulted in short-term reduction in costs in male patients and patients younger than 85 years.

Identifiants

pubmed: 36346006
doi: 10.1177/15266028221133694
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

15266028221133694

Auteurs

Ahmed A Naiem (AA)

Division of vascular surgery, Royal Victoria Hospital, McGill University, Montreal, QC, Canada.

R J Doonan (RJ)

Division of vascular surgery, Royal Victoria Hospital, McGill University Health Centre, Montreal, QC, Canada.

Andre Guigui (A)

Financial systems and process improvement finance, McGill University Health Centre, Montreal, QC, Canada.

Daniel I Obrand (DI)

Division of vascular surgery, Jewish General Hospital, Montreal, QC, Canada.

Jason P Bayne (JP)

Division of vascular surgery, Jewish General Hospital, Montreal, QC, Canada.

Kent S MacKenzie (KS)

Division of vascular surgery, Royal Victoria Hospital, McGill University Health Centre, Montreal, QC, Canada.

Oren K Steinmetz (OK)

Division of vascular surgery, Royal Victoria Hospital, McGill University Health Centre, Montreal, QC, Canada.

Elie Girsowicz (E)

Division of vascular surgery, Jewish General Hospital, Montreal, QC, Canada.

Heather L Gill (HL)

Division of vascular surgery, Royal Victoria Hospital, McGill University Health Centre, Montreal, QC, Canada.

Classifications MeSH